According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
The owners of a vast floating artificial island that had been planned for last summer off the coast of Mandelieu have won a legal battle to be allowed...
Read More
The Monegasque State has successfully conducted its first national voluntary surrender operation, with 123 firearms being handed over by private indiv...
Read More
A hospital in Cannes has had to postpone all non-urgent consultations and operations after falling victim to a cyberattack....
Read More
Potential presence of broken glass in pizzas. A recall has been issued for several pizzas distributed by Auchan Avallon in France due to the potential...
Read More
The Riviera's ski resorts are celebrating a record winter season.
Read More
